Benamer H, Steg P G, Benessiano J, Vicaut E, Gaultier C J, Boccara A, Aubry P, Nicaise P, Brochet E, Juliard J M, Himbert D, Assayag P
Service de Cardiologie, Hôpital Bichat, Paris, France.
Am J Cardiol. 1998 Oct 1;82(7):845-50. doi: 10.1016/s0002-9149(98)00490-1.
This study assessed the prognostic value of cardiac troponin I (cTnI) and C-reactive protein (CRP) in unstable angina, and specifically in patients with angiographically proven coronary artery disease. These biochemical parameters, which are related to myocardial injury or to systemic inflammation, may help in short-term risk stratification of unstable angina. We prospectively studied 195 patients with unstable angina, 100 of whom had angiographically proven coronary artery disease (with normal creatine kinase [CK] and CK-MB mass). Serum concentrations of cTnI (N < 0.4 ng/ml) and CRP (N < 3 mg/L) were measured at admission, 12, and 24 hours later. The rate of in-hospital major adverse cardiac events (death, myocardial infarction, or emergency revascularization) was higher in patients with increased cTnI within the first 24 hours, regardless of the results of coronary angiography (23% vs 7%; p < 0.001). Conversely, events occurred at similar rates in patients with or without increased CRP. In patients with angiographic evidence of coronary artery disease, multivariate analysis showed that increased cTnI within 24 hours of admission (35 patients) was an independent predictor of major adverse cardiac events (odds ratio 6.7, range 1.7 to 27.3), but not cTnI levels at admission and CRP at 0, 12, and 24 hours. Thus, both in unselected patients with unstable angina and in patients with angiographically proven coronary artery disease, increased cTnI within 24 hours of admission, but not CRP, is a predictor of in-hospital clinical outcome. We also found a temporal link between cTnI increase and late elevation of CRP, suggesting that systemic inflammation may partially be a consequence of myocardial injury.
本研究评估了心肌肌钙蛋白I(cTnI)和C反应蛋白(CRP)在不稳定型心绞痛患者,尤其是经血管造影证实患有冠状动脉疾病的患者中的预后价值。这些与心肌损伤或全身炎症相关的生化参数,可能有助于对不稳定型心绞痛进行短期风险分层。我们前瞻性地研究了195例不稳定型心绞痛患者,其中100例经血管造影证实患有冠状动脉疾病(肌酸激酶[CK]和CK-MB质量正常)。在入院时、12小时和24小时后测定血清cTnI(正常范围<0.4 ng/ml)和CRP(正常范围<3 mg/L)浓度。无论冠状动脉造影结果如何,入院后24小时内cTnI升高的患者发生院内主要不良心脏事件(死亡、心肌梗死或急诊血运重建)的发生率更高(23%对7%;p<0.001)。相反,CRP升高或未升高的患者发生事件的发生率相似。在有冠状动脉疾病血管造影证据的患者中,多因素分析显示入院后24小时内cTnI升高(35例患者)是主要不良心脏事件的独立预测因素(比值比6.7,范围1.7至27.3),但入院时的cTnI水平以及0、12和24小时的CRP水平不是。因此,在未经选择的不稳定型心绞痛患者和经血管造影证实患有冠状动脉疾病的患者中,入院后24小时内cTnI升高而非CRP升高是院内临床结局的预测因素。我们还发现cTnI升高与CRP后期升高之间存在时间关联,提示全身炎症可能部分是心肌损伤的结果。